Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upper GI Handling of Branded vs Generic Alendronate
NCT00400530Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, single-blind trial of alendronate in osteoporosis (2 arms), sponsored by Merck & Co. Primary endpoint: Gamma camera imaging of tablet dissolution in oesophagus. Started Dec 2005; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00400530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400530.